05 Compliance

Where L-tyrosine is permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-19 · L-Tyrosine

On this page
  1. The four checks
  2. European Union
  3. United States
  4. Contaminant limits
  5. The claim boundary
  6. The document file
  7. The checklist

L-tyrosine is used as a food supplement ingredient in the EU, the US and the UK, but the permission, the contaminant ceiling, the label wording and the claim are four separate checks. The EU has no harmonised positive list for amino acids in supplements; the US regulates L-tyrosine as a dietary ingredient under DSHEA; the UK applies retained EU law. The file has to show the form, the market and the evidence for each check.

In one line

Ingredient status, contaminant ceilings, label wording and claims are four separate checks, and each market answers them in its own instrument.

The four checks

The first question is whether the ingredient may be sold in the market at all. The second is whether the finished product stays under the contaminant limits. The third is whether the label names the ingredient and the amount correctly. The fourth is whether any health claim attached to it is authorised and substantiated. A batch certificate supports all four, but it replaces none of them.

The operator placing the product on the market owns the file. A supplier's certificate is an input, not a defence, and the rules below are a sourcing reference rather than legal advice. Each market's current text and the destination's national guidance decide the label.

European Union

Directive 2002/46/EC harmonises food supplements, but its positive list in Annex II covers vitamins and minerals, not amino acids. L-tyrosine therefore sits under general food law, Regulation (EC) No 178/2002, and under any national rules the destination Member State applies. It has a history of use before 15 May 1997 and is not a novel food; confirm the entry in the EU Novel Food Catalogue for the specific form.

There is no harmonised maximum level for tyrosine in a supplement, and some Member States apply their own notification or composition rules. The supplement particulars come from Directive 2002/46/EC and the general labelling rules from Regulation (EU) No 1169/2011. N-acetyl-L-tyrosine (NAT) is a different ingredient with a different status file; a permission for L-tyrosine does not carry over to it.

United States

L-tyrosine is a dietary ingredient under DSHEA. The supplier should be able to support the position that it was marketed in the US before 15 October 1994; an ingredient in that position does not need a new dietary ingredient notification. The product is made under the dietary supplement cGMP in 21 CFR 111, and the panel follows 21 CFR 101.36. The FDA does not approve supplements or their ingredients before sale, so the file is the evidence.

A structure/function claim is allowed if it is truthful, not misleading and substantiated, and if the label carries the DSHEA disclaimer. The manufacturer must notify the FDA within 30 days after marketing a product with such a claim. A claim that names a disease, or that implies a disease outcome, is outside that route. Advertising is also subject to FTC substantiation.

Contaminant limits

Heavy-metal limits that apply to a food supplement · EU, US and UK
MetalEU · Regulation (EU) 2023/915US federalUK retained limits
Lead3.0 mg/kg in food supplementsNo numeric federal limit; cGMP applies3.0 mg/kg
Cadmium1.0 mg/kg; 3.0 mg/kg for seaweed-based supplementsNo numeric federal limit; cGMP applies1.0 mg/kg
Mercury0.10 mg/kgNo numeric federal limit; cGMP applies0.10 mg/kg
ArsenicNo harmonised limit for supplements; the buyer sets oneNo numeric federal limit; cGMP appliesNo harmonised limit; the buyer sets one

Two points decide how those figures are used. First, the EU and UK limits apply to the food as placed on the market, not to the drum. The raw-material limit is a purchasing limit, and it needs headroom for method uncertainty, other ingredients and the finished-product test. Second, the US federal position is not a numeric ceiling. California's Proposition 65 sets a lead maximum allowable dose level of 0.5 µg per day, a cadmium level of 4.1 µg per day and an inorganic arsenic level of 10 µg per day, so a daily dose can require a warning even when no federal limit is broken.

The catalog limits for L-tyrosine are Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg. The lead, cadmium and mercury figures sit at or below the EU and UK ceilings; the arsenic figure is a buyer-set limit because neither regime sets a harmonised one for supplements.

The claim boundary

In the EU and the UK, a health claim must be authorised and appear in the applicable Register; Regulation (EC) No 1924/2006 also requires the claim to be truthful, clear and substantiated. As of this review the EU Register does not list an authorised claim for L-tyrosine as such, so the label should not attach a body-function claim to the ingredient unless a current entry is found. The same check applies in the GB Register.

In the US, a structure/function claim is possible under DSHEA with the disclaimer and the FDA notification, but a disease claim is not. The practical test is the same in all three markets: the claim has to describe the product, not a disease, and the file has to carry the evidence behind it.

The document file

Documents a brand should hold for an L-tyrosine lot
DocumentWhat it supportsMarket
Batch certificate of analysisRelease against the specification, with methods and resultsAll
SpecificationThe agreed limits, methods and basisAll
Technical data sheetSolubility, particle size, handling and packAll
Safety data sheetHazard and handling informationAll
Allergen and GMO statementsComposition and labelling declarationsEU, UK, US
Novel food or dietary ingredient statementThe market entry position for the formEU, UK, US
Origin and manufacturer statementTraceability and the source routeAll
Heavy-metal and micro reportsThe contaminant and hygiene envelopeAll
Packaging and food-contact declarationThe pouch or drum in contact with the powderEU, UK, US

The checklist

  1. Name the form and match CAS 60-18-4; NAT is a different ingredient.
  2. Confirm the market entry position for that form, including the Member State rules in the EU and the GB Register in the UK.
  3. Set the raw-material contaminant limits below the finished-product ceiling, and set an arsenic limit because the EU and UK do not.
  4. Check the daily dose against the contaminant figures and, for the US, against the Proposition 65 dose levels.
  5. Match the label name and the declared amount to the certificate and the purchase order.
  6. Check every claim against the Register or the DSHEA route.
  7. Collect the documents in the table against the lot number, not against the product name alone.
  8. Ask for the source route and the animal-derived input statement, because fermentation and synthesis routes carry different declarations.

The release tests behind the file are on the COA page, the form choice on the grade page and the L-tyrosine versus NAT page, and the identity evidence on the identity page. The product hub carries the catalog specification, the metals are described in the ICP-MS method note, and heavy metals is defined in the glossary.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation